INNV-Earnings are going to be great no doubt but more importantly they expect to have positive earnings per share for 2017. Recently signed a 20 million dollar deal, FDA could approve Fluticare soon and with positive earnings this year we could be looking at a 5 to 10 bagger over the next 1 to 2 years.
(1)
(0)
Innovus Pharmaceuticals Inc. (INNV) Stock Research Links